Foreword

Microbial resistance to conventional therapies has transformed healthcare practice, compelling researchers to reconsider bacterial behaviour patterns. Most pathogenic bacteria develop within complex biofilm matrices rather than existing as isolated cells. These structured communities demonstrate remarkable phenotypic differences from their planktonic forms, particularly in antimicrobial susceptibility.

Biofilms present formidable clinical challenges through their enhanced resistance mechanisms. Laboratory studies reveal resistance increases up to 1000-fold compared to free-floating bacteria. Healthcare systems worldwide report that biofilm-related infections comprise approximately 65% of bacterial infections, contributing substantially to treatment failures and healthcare costs.

Quorum sensing governs biofilm development through bacterial communication networks. This population-density mechanism coordinates group behaviours via small signalling molecules called autoinducers. Beyond structural regulation, these systems control virulence expression, metabolic pathways, and environmental stress responses. Recent discoveries in interkingdom communication have revealed how bacterial signals influence plant and animal host responses.

This comprehensive volume examines current biofilm research from multiple perspectives. The authors systematically present molecular foundations while exploring innovative therapeutic approaches. Traditional antimicrobial strategies prove insufficient against mature biofilms, necessitating alternative interventions. The book evaluates promising developments, including quorum disruption techniques, phytochemical compounds, engineered nanoparticles, and bacteriophage applications.

Modern biofilm research demands interdisciplinary collaboration across microbiology, chemistry, engineering, and medicine. The contributing scientists represent diverse specializations, ensuring broad coverage of contemporary research directions. Their collective work spans basic science discoveries through clinical translation studies.

The timing proves particularly relevant as biofilm-associated infections increasingly challenge medical practice. Industrial sectors also face biofilm contamination problems affecting manufacturing processes and infrastructure maintenance. Environmental applications include bioremediation and water treatment systems, where biofilm control remains problematic.

Future treatment strategies must incorporate a detailed understanding of biofilm biology and quorum-sensing mechanisms. This book provides essential background knowledge while highlighting emerging research opportunities. The comprehensive approach serves multiple audiences, including graduate students, postdoctoral researchers, and established investigators seeking current perspectives on biofilm science.